|
|||||
|
|
| 间质性肺疾病相关性肺高压 | |
| 引用本文： | 毕娅兰,许文兵. 间质性肺疾病相关性肺高压[J]. 国际呼吸杂志, 2010, 30(16). DOI: 10.3760/cma.j.issn.1673-436X.2010.016.014 |
| 作者姓名： | 毕娅兰 许文兵 |
| 作者单位： | 北京协和医学院, 北京协和医院病理科, 中国医学科学院,100730;北京协和医学院, 北京协和医院呼吸科, 中国医学科学院,100730 |
| 摘 要： | 临床上发现与间质性肺疾病相关的肺高压存在相当的发病率和死亡率.各种新的药物和肺移植使得治疗方法有了更多选择,但是这些先进疗法的远期疗效和毒副作用还有待进一步观察研究. |
| 关 键 词： | 间质性肺疾病 肺高压 波生坦 依前列醇 西地那非 |
Pulmonary hypertension associated with interstitial lung disease |
|
| BI Ya-lan,XU Wen-bing. Pulmonary hypertension associated with interstitial lung disease[J]. International Journal of Respiration, 2010, 30(16). DOI: 10.3760/cma.j.issn.1673-436X.2010.016.014 | |
| Authors: | BI Ya-lan XU Wen-bing |
| Abstract: | In clinic, pulmonary hypertension associated with interstitial lung disease has considerable morbidity and mortality. Many new drugs and lung transplantation increase the treatment options for the disease. But the prostecdtive efficacy and side effects of advanced therapies remain uncertain. |
| Keywords: | Interstitial lung disease Pulmonary hypertension Bosentan Epoprostenol Sidenafil |
| 本文献已被 万方数据 等数据库收录！ | |